All stock reports

AKI evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-26T23:16:18.920640+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1073275000.0
net_income
24066000.0
operating_cash_flow
-159075000.0
free_cash_flow
-209951000.0
total_assets
1601446000.0
total_liabilities
598239000.0
total_equity
1003207000.0
cash
46931000.0
total_debt
214494000.0
revenue_growth
0.3256560501372252
earnings_growth
0.4343783526046012
net_margin
0.02242295776944399
roe
0.023989067061932382
debt_to_equity
0.21380831672825248
cash_conversion
-6.609947643979058
free_cash_flow_margin
-0.19561715310614708
trailing_pe
23.1579
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
0.4609
dividend_yield
Not supplied

Other positional research

Research only

2 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied

Trend Continuation Pullback

Research only. Direction: LONG.

Tests continuation after a controlled retracement within an established trend

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Price breach below slow EMA
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-cecc1fb5c1e496227fddd8ab63712164500bd692c523bab93fe222d4084707d2
Policy
stock-decisions-v1
Evidence bundle hash
80fdbcb9215eb96df7506dca824058923d51b590a2f1f1b1892a4c40f288f950
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: b44534c7508ad90bb780abb13ccb9c8f6effc3de4d3df669fa1fc9fd48d65288
  • daily-price: e550a57a4b86d8a54a356998b058c7595e8679561dd8b48328a6a9cdd0800f75
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: REPAIRED. The trailing 20-session price return was 12.41%. The trailing 60-session price return was 33.05%. The cached financial metric revenue growth is 0.3256560501372252. The cached financial metric roe is 0.023989067061932382. The cached financial metric debt to equity is 0.21380831672825248.

Risks

The trailing 5-session price return was -10.07%. The trailing 250-session price return was -34.68%. The closing price was -37.33% below its highest close in the available trailing year. Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric cash conversion is -6.609947643979058. The cached financial metric free cash flow margin is -0.19561715310614708.

Follow Up

Price source verification: REPAIRED. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Cached observations and evidence limits